Lynn Madden, PhD, MPA
Assistant Professor AdjunctCards
Appointments
Infectious Diseases
Primary
Titles
President/CEO, Administration
Contact Info
Appointments
Infectious Diseases
Primary
Titles
President/CEO, Administration
Contact Info
Appointments
Infectious Diseases
Primary
Titles
President/CEO, Administration
Contact Info
About
Titles
Assistant Professor Adjunct
President/CEO, AdministrationBiography
Since 2006, I have served as Chief Executive Officer of the APT Foundation, a non-profit agency founded in 1970 by members of the Yale University Department of Psychiatry to promote health and recovery for those who live with substance use disorders and/or mental illness. My professional interests focus on identifying treatment gaps in substance abuse/mental health treatment and improving access to those services including services for persons who are incarcerated or recently released from jail or prison.
My academic interests and pursuits include large- and small-scale implementation projects that are focused on access to and quality in mental health care and substance abuse treatment services including integration with primary care, and integration of treatment for infectious diseases such as HIV/AIDS and HCV. My role in these project teams is often as both coach and researcher. I currently hold a position as an assistant professor in the Yale School of Medicine AIDS program and as a faculty member in addiction medicine.
Appointments
Infectious Diseases
Assistant Professor AdjunctPrimary
Other Departments & Organizations
- Addiction Medicine Fellowship Program
- Infectious Diseases
- Internal Medicine
- J. Meyer Lab
- Yale-UPR Integrated HIV Basic and Clinical Sciences Initiative
Education & Training
- PhD
- Union Institute & University, Interdisciplinary Studies/Public Policy and Social Change (2017)
- MPA
- University of Maine (1997)
- BA
- University of Maine (1995)
Research
Overview
Since 2004, the focus of my work has been the relationship between improved access to care, particularly mental health, substance abuse and infectious diseases treatment, and the resultant improvements in both patient outcomes and financial performance. I have contributed to the refinement and theoretical understanding of the rapid cycle process improvement model as advanced by NIATX (www.NIATx.net) headquartered at the University of Wisconsin-Madison. I have used this model as both a coach and a researcher in working with individual organizations, state level learning collaboratives, and learning collaboratives composed of organizations throughout the US and in Ukraine. Specific contributions to science cluster in three areas: Improving Access to and Retention in Substance Abuse Treatment, Enhancing Integration Between Substance Abuse Treatment Services and Infectious Diseases, and
Developing Strategies for Systems and Clinicians to Respond Effectively to Complex Patients.
Research at a Glance
Yale Co-Authors
Frequent collaborators of Lynn Madden's published research.
Publications Timeline
A big-picture view of Lynn Madden's research output by year.
Frederick Lewis Altice, MD, MA
Declan Barry, PhD
Mark Beitel, PhD
Jeanette Tetrault, MD, FACP, FASAM
Carolina E Price, MPA
Robert Kerns, PhD
83Publications
1,047Citations
Publications
2024
The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine
Ivasiy R, Madden L, Meteliuk A, Machavariani E, Ahmad B, Zelenev A, Desai M, Bromberg D, Polonsky M, de Leon S, Farnum S, Islam Z, Altice F. The impact of emergency guidance to the COVID‐19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine. Addiction 2024 PMID: 38807448, DOI: 10.1111/add.16565.Peer-Reviewed Original ResearchAltmetricConceptsOpioid agonist therapyTake-home dosesCOVID-19 guidancePre-COVID cohortAgonist therapyOptimal doseTreatment retentionEmergency guidanceEffective HIV prevention strategiesAdult HIV prevalenceHIV prevention strategiesMinistry of HealthImprove treatment retentionMethadone dosePatient survivalTime-dependent predictorsProspective cohortHIV prevalencePredictors of treatment retentionGovernmental clinicsPrimary outcomeHazard ratioPatient enrollmentPatientsMethadone patientsPerceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment.
Gaeta Gazzola M, Oberleitner L, Hoffman K, Eller A, Madden L, Marcus R, Oberleitner D, Beitel M, Thompson E, Zheng X, Barry D. Perceptions of Community Corrections and Treatment Experience: A Qualitative Study Among People With Incarceration Histories Receiving Outpatient Methadone Treatment. Substance Use & Addiction Journal 2024, 29767342241238837. PMID: 38551080, DOI: 10.1177/29767342241238837.Peer-Reviewed Original ResearchConceptsCommunity corrections officersCommunity corrections systemCorrection systemCommunity correctionsTreatment facilitatorsOpioid use disorderCorrective experiencesMethadone treatmentSubstance use disorder careCommunity supervisionCorrectional officersQualitative studyCoercive treatmentIncarceration historyOutpatient methadone treatmentIncarcerationDemographic surveyQualitative research teamNegative experiencesNegative perceptionsCommunitySemistructured interviewsPositive perceptionsInterviewsParoleA Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment
Gazzola M, Carmichael I, Thompson E, Beitel M, Madden L, Saeed G, Hoffman K, Hammouri M, Hsaio C, Barry D. A Quantitative Examination of Illness Models Among People With Opioid Use Disorder Receiving Methadone Treatment. Journal Of Addiction Medicine 2024, 18: 262-268. PMID: 38446859, DOI: 10.1097/adm.0000000000001282.Peer-Reviewed Original ResearchAltmetricConceptsBrain disease modelMethadone treatmentTreatment beliefsIllness modelAssociated with beliefsOpioid use disorderUse disorderOutpatient opioid treatment programAddiction modelTreatment programsOpioid treatment programsAddictionMethadoneMultivariate analysisScale agreementIllnessDisordersCounselingBrainBeliefsDisease modelsOpioidPatientsStatistical significanceMultivariate regressionIntegrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge
Bromberg D, Machavariani E, Madden L, Dumchev K, LaMonaca K, Earnshaw V, Pykalo I, Filippovych M, Haddad M, Dvoriak S, Altice F. Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge. Journal Of The International AIDS Society 2024, 27: e26202. PMID: 38379179, PMCID: PMC10879646, DOI: 10.1002/jia2.26202.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPrimary care clinicsStigma reduction interventionsOpioid agonist therapyClinicians' attitudesStigma constructsHIV preventionReduction interventionsEvidence-based HIV preventionCluster randomized controlled trialEvidence-based carePrimary care settingIntegrated care sitesDirect providersRandomized controlled trialsProvider stigmaCare clinicsCare sitesHIV careCare settingsHealth outcomesClinical staffSubstance use disordersLinear mixed-effects modelsTreatment continuumImprove attitudesPreferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.
Bromberg D, Madden L, Fraenkel L, Muthulingam D, Rhoades D, Dvoriak S, Dumchev K, Pykalo I, Altice F. Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey. PLOS Global Public Health 2024, 4: e0002725. PMID: 38277422, PMCID: PMC10817130, DOI: 10.1371/journal.pgph.0002725.Peer-Reviewed Original ResearchCitationsConceptsOpioid agonist therapyWithdrawal symptomsAdverse side effectsAgonist therapySide effectsOpioid use disorderQuality-of-life improvementUse disorderCombined HIVHIV incidenceClinical decision-makingDosing frequencyRespondent-driven samplingOpioidOpioid epidemicAssess preferencesClinical concernPatient preferencesPatientsDelivery strategiesTherapyDisordersHIVPatient concernsWithdrawalCorrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
Galvez S, Altice F, Meteliuk A, Ivasiy R, Machavariani E, Farnum S, Fomenko T, Islam Z, Madden L. Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine. Frontiers In Public Health 2024, 11: 1359708. PMID: 38274528, PMCID: PMC10809844, DOI: 10.3389/fpubh.2023.1359708.Peer-Reviewed Original ResearchStalled Scale-Up of Opioid Agonist Therapies for HIV Prevention in Kazakhstan: History, Policy, and Recommendations for Change
Liberman A, Ivasiy R, Altice F, Bromberg D, Ibragimova O, Seksenova Z, Madden L, Primbetova S, Terlikbayeva A. Stalled Scale-Up of Opioid Agonist Therapies for HIV Prevention in Kazakhstan: History, Policy, and Recommendations for Change. Journal Of Illicit Economies And Development 2024, 5: 69-77. DOI: 10.31389/jied.208.Peer-Reviewed Original ResearchCitationsAltmetric
2023
High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
Galvez S, Altice F, Meteliuk A, Ivasiy R, Machavariani E, Farnum S, Fomenko T, Islam Z, Madden L. High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine. Frontiers In Public Health 2023, 11: 1231581. PMID: 38098837, PMCID: PMC10720365, DOI: 10.3389/fpubh.2023.1231581.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid agonist therapyOpioid use disorderAgonist therapyOAT patientsCOVID-19 pandemicSubstance useTake-home dosingAdditional psychosocial supportHigher perceived stressHigh riskPerceived Stress ScalePsychiatric disordersUse disordersPatientsPatient stressPsychosocial supportCertain subgroupsSevere levelsHigh levelsHealthcare deliveryStress ScalePerceived stressTherapyExtraordinary high levelsDisordersPreferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis
Muthulingam D, Hassett T, Madden L, Bromberg D, Fraenkel L, Altice F. Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis. Journal Of Substance Use And Addiction Treatment 2023, 154: 209138. PMID: 37544510, DOI: 10.1016/j.josat.2023.209138.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid use disorderRoute of administrationPatient preferencesUse disordersSymptom reliefTreatment preferencesSide effectsCross-sectional observational studyTreatment-seeking peopleChi-squared analysisOral medicationsPublic health crisisOUD treatmentTreatment uptakeWithdrawal symptomsOpioid epidemicObservational studyTreatment decisionsSTROBE checklistSustainability of treatmentPatientsMedicationsHealth professionalsUtility scoresLarger studyImproving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches
Brooks R, Wegener M, Freeman B, Fowles C, Madden L, Tetrault J, Nichols L, Altice F, Villanueva M. Improving HIV and HCV Testing in Substance Use Disorder Programs (SUDs) That Provide Medications for Opiate Use Disorder (MOUD): Role of Addressing Barriers and Implementing Universal and Site-Specific Approaches. Health Promotion Practice 2023, 24: 1018-1028. PMID: 37439759, DOI: 10.1177/15248399231169791.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHIV/HCV coinfectionSubstance use disorder programsHCV testingOpiate use disorderHCV coinfectionUse disordersNominal group techniqueSubstance use disorder treatment centersCascade of careRates of HIVDisorder treatment centersQuality improvement effortsRate of testingHCV acquisitionHCV cureImproving HIVSUD clinicsHepatitis CHIV testingPrior diagnosisSubsequent referralReferral ratesHIV epidemicHIVTreatment centers
Links & Media
News
- October 27, 2023
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
- July 21, 2023
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
- November 16, 2022
Discoveries & Impact (November 2022)
- October 10, 2022
Patients Receiving Methadone Treatment Prefer Clinicians Use Medically Accurate and Destigmatizing Language